
Hongxin Bio
虹信生物
Hongxin Bio
Biotech/Healthcare
Hongxin Biotech is an mRNA drug developer focused on nucleic acid drug delivery and RNA therapeutics. With deep expertise in nucleic acid delivery, the company has developed a library of ionizable amino lipids with fully independent intellectual property rights.
Latest round: Series B (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-08-13
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.